BackSonnet BioTherapeutics Holdings Overview

Sonnet BioTherapeutics Holdings Total Revenue

Revenue analysis for SONN.

Quarterly Revenue

N/A

As of Sep 2025

Annual Revenue (TTM)

$1.00M
↓ 89.01% YoY

Trailing 12 months ending Sep 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin